2022 M05 18
ABP Nocivelli
Visibility on resilient EBITDA at undemanding multiples
Sponsored Research
Le nostre ricerche sponsored, report e news flow per società quotate del mercato italiano.
2022 M05 17
Net Insurance
Solid FY 21 and Q1 22 results; waiting for the new plan
2022 M04 29
Shedir Pharma
FY 21 results in line with expectations and positive outlook on 2022
2022 M04 12
Osai
Robust order intake ensures good visibility on 2022 growth
2021 M11 29
Shedir Pharma
H1 21 sales and profitability in line with H1 20
2021 M10 11
DeA Capital
H1 21: cash and the fee-based business are still the main drivers
Sponsored Reserach